SEC Form 4 · accession 0000899243-19-000577
Allena Pharmaceuticals, Inc. · ALNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis Brenner M.D.
Officer — President and COO
Period of report
Jan 4, 2019
Accepted (ET)
Jan 4, 2019 · 9:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001624658
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $7.03 | Jan 4, 2019 | A | 305,000 | A | — | Jan 3, 2029 | Common Stock | 305,000 | 305,000 | D |
Explanation of responses
- F1Stock option shall vest over a four-year period beginning February 1, 2019, with 25% vesting on the one-year anniversary of the vesting commencement date and the balance vesting ratably on a monthly basis over the remaining three-year period.